Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results

Overview of attention for article published in Clinical Ophthalmology, June 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 8,218 followers.

やってみたい🥰💓

Upneeqのphase3臨床試験の結果をまとめた論文。本試験では、203人の眼瞼下垂患者を薬剤群とプラセボ群に分け、点眼前、点眼後2時間と6時間におけるまぶたの高さを比較しました。開始前、1日目、14日目、42日目に測定されています。 https://t.co/pPT0alhWIW

Ophthopedia Update: Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results https://t.co/Iv5DxEVTTA #Ophthomology #Eye #Ophthotwitter